Cetera Investment Advisers - PDS BIOTECHNOLOGY CORP ownership

PDS BIOTECHNOLOGY CORP's ticker is PDSB and the CUSIP is 70465T107. A total of 47 filers reported holding PDS BIOTECHNOLOGY CORP in Q2 2021. The put-call ratio across all filers is 1.46 and the average weighting 0.2%.

Quarter-by-quarter ownership
Cetera Investment Advisers ownership history of PDS BIOTECHNOLOGY CORP
ValueSharesWeighting
Q2 2023$61,944
-42.0%
12,315
-29.1%
0.00%0.0%
Q1 2023$106,795
+167.0%
17,365
+59.8%
0.00%0.0%
Q2 2022$40,000
-51.8%
10,865
-18.7%
0.00%0.0%
Q1 2022$83,000
-36.6%
13,365
-17.6%
0.00%
-50.0%
Q4 2021$131,000
-54.0%
16,215
-15.2%
0.00%
-60.0%
Q3 2021$285,000
+493.8%
19,115
+82.0%
0.01%
+400.0%
Q1 2021$48,00010,5000.00%
Other shareholders
PDS BIOTECHNOLOGY CORP shareholders Q2 2021
NameSharesValueWeighting ↓
INSPIRION WEALTH ADVISORS, LLC 314,119$933,0000.21%
New Leaf Venture Partners, L.L.C. 117,242$348,0000.21%
Iron Gate Global Advisors LLC 75,016$223,0000.06%
ACT CAPITAL MANAGEMENT, LLC 12,000$36,0000.05%
KNIGHTSBRIDGE ASSET MANAGEMENT, LLC 43,916$130,0000.03%
Andesa Financial Management Inc. 25,000$74,0000.03%
Sofinnova Investments, Inc. 142,635$424,0000.02%
Ellis Investment Partners, LLC 6,850$20,0000.01%
OCCUDO QUANTITATIVE STRATEGIES LP 22,496$67,0000.01%
Valeo Financial Advisors, LLC 21,570$64,0000.00%
View complete list of PDS BIOTECHNOLOGY CORP shareholders